Resonance Health Ltd

ASX:RHT (Australia)  
A$ 0.07 (0%) Mar 19
At Loss
P/B:
3.34
Market Cap:
A$ 31.28M ($ 20.46M)
Enterprise V:
A$ 25.70M ($ 16.82M)
Volume:
67.93K
Avg Vol (2M):
201.01K
Also Trade In:
Volume:
67.93K
At Loss
Avg Vol (2M):
201.01K

Business Description

Description
Resonance Health Ltd is a healthcare company specializing in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its product includes FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver, and HepaFat-Scan. The company's operating segment includes Services; Research and Development and Corporate. It generates maximum revenue from the Services segment. Geographically, it derives a majority of its revenue from North America and Europe-Middle-East-Africa (EMEA) and also has a presence in Asia/Pacific.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 18.37
Equity-to-Asset 0.9
Debt-to-Equity 0.03
Debt-to-EBITDA -0.32
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 11.01
Distress
Grey
Safe
Beneish M-Score -3.06
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 7.7
3-Year EBITDA Growth Rate -14.5

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 62.68
9-Day RSI 65.4
14-Day RSI 64.67
6-1 Month Momentum % -15.38
12-1 Month Momentum % 19.57

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.25
Quick Ratio 8.25
Cash Ratio 6.63
Days Sales Outstanding 74.9

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.3
Shareholder Yield % -0.01

Financials

ASX:RHT's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Resonance Health Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 5.57
EPS (TTM) (A$) -0.002
Beta 1.23
Volatility % 60.55
14-Day RSI 64.67
14-Day ATR (A$) 0.003163
20-Day SMA (A$) 0.06105
12-1 Month Momentum % 19.57
52-Week Range (A$) 0.037 - 0.088
Shares Outstanding (Mil) 446.89

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Resonance Health Ltd Filings

Filing Date Document Date Form
No Filing Data

Resonance Health Ltd Stock Events

Financials Calendars
Event Date Price(A$)
No Event Data

Resonance Health Ltd Frequently Asked Questions

What is Resonance Health Ltd(ASX:RHT)'s stock price today?
The current price of ASX:RHT is A$0.07. The 52 week high of ASX:RHT is A$0.09 and 52 week low is A$0.04.
When is next earnings date of Resonance Health Ltd(ASX:RHT)?
The next earnings date of Resonance Health Ltd(ASX:RHT) is .
Does Resonance Health Ltd(ASX:RHT) pay dividends? If so, how much?
Resonance Health Ltd(ASX:RHT) does not pay dividend.

Press Release

Subject Date
No Press Release